Von Willebrand factor (vWF) antigen levels and function in healthy thais

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 36, Issue 5, 2005, Pages 1292-1297

  Rojnuckarin, Ponlapat ^a   Akkawat, Benjaporn ^a   Intragumtornchai, Tanin ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 30344488163     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bowen DJ. An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 2003; 1: 33-40.
2. Chuansumrit A, Mahasandana C, Chinthammitr Y, et al. National survey of patients with hemophilia and other congenital bleeding disorders in Thailand. Southeast Asian J Trop Med Public Health 2004; 35: 445-9
3. Coppola R, Mari D, Lattuada A, Franceschi C. von Willebrand factor in Italian centenarians. Haematologica 2003; 88: 39-43.
4. Dean JA, Blanchette VS, Carcao MD, et al. von Willebrand disease in a pediatric-based population-comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost 2000; 84: 401-9.
5. Favaloro EJ, Grispo L, Dinale A, Berndt M, Koutts J. von Willebrand's disease: laboratory investigation using an improved functional assay for von Willebrand factor. Pathology 1993; 25: 152-8.
6. Favaloro EJ. Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrand's Disease (VWD), and discrimination of VWD subtypes, depends on collagen source. Thromb Haemost 2000; 83: 127-35.
7. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montagomory RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
8. Kunicki TJ, Federici AB, Salomon DR, et al. An association of candidate gene haplotypes and bleeding severity in Von Willebrand Disease (VWD) type 1 pedigrees. Blood 2004; 104: 2359-67.
9. Laffan M, Brown SA, Collins PW, et al. The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation. Haemophilia 2004; 10: 199-217.
10. Mannucci PM, Coppola R. von Willebrand factor. In: Jespersen J, Bertina RM, Haverkate F, eds. Laboratory techniques in thrombosis- a manual. Kluwer Academic Publishers, 1999: 115-9.
11. Miller CH, Dilley A, Richardson L, Craig Hooper W, Evatt BL. Population differences in vWF levels affect the diagnosis of vWD on African-American women. Am J Hematol 2001; 67: 125-9.
12. Nitu Whalley IC, Lee CA, Griffioen A, Jenkins PV, Pasi KJ. Type I von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of bleeding history. Br J Haematol 2000; 108: 259-64.
13. O'Donnell J, Boulton FE, Manning RA, Laffan MA. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arterioscler Thromb Vasc Biol 2002; 22: 335-41.
14. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454-9.
15. Rodeghiero F, Castaman G, Tosetto A. von Willebrand factor antigen is less sensitive than ristocetin cofactor in diagnosis of type I von Willebrand disease-result based on an epidemiological investigation. Thromb Haemost 1990; 64: 349-52.
16. Sadler JE. Von Willebrand disease type I: a diagnosis in search of a disease. Blood 2003; 101: 2089-93.
17. Sarode R, Goldstein J, Sussman II, Nagel RL, Tsai HM. Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor. Br J Haematol 2000; 109: 857-64.
18. Shima M, Fujimura Y, Nishiyama T, et al. ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang 1995; 68: 236-40.
19. Souto JC, Almsay L, Muniz-Diaz E, et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 2000; 20: 2024-8.
20. Sukhu K, Poovalingam V, Mahomed R, Giangrande PLF. Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease. Clin Lab Haematal 2003; 25: 247-9.
21. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995; 332: 635-41.
22. Werner EJ, Broxson EH, Tucker EL, et al. Prevalence of von Willebrand disease in children; a multiethnic study. J Pediatr 1993; 123: 349-52.
23. Whincup PH, Danesh J, Walker M, et al. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002; 23: 1764-70.
24. Zhang L, Li H, Zhao H, Zhang X, Ji L, Yang R. Retrospective analysis of 1312 patients with haemophilia and related disorders in a single Chinese institute. Haemophilia 2003; 9: 696-702.